Quantitative System Risk Assessment From Incomplete Data With Belief Networks and Pairwise Comparison Elicitation. [PDF]
De Persis C +4 more
europepmc +1 more source
A probability prediction method for the classification of surrounding rock quality of tunnels with incomplete data using Bayesian networks. [PDF]
Ma J +6 more
europepmc +1 more source
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce +72 more
wiley +1 more source
Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy. [PDF]
Molin D.
europepmc +1 more source
Prediction of Duration of Traffic Incidents by Hybrid Deep Learning Based on Multi-Source Incomplete Data. [PDF]
Shang Q, Xie T, Yu Y.
europepmc +1 more source
A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling +16 more
wiley +1 more source
Constructing a binary prediction model with incomplete data: Variable selection to balance fairness and precision. [PDF]
Ren H, Wang C, Xu G, Weiss DJ.
europepmc +1 more source
Negative COVID-19 excess mortality in the Philippines: outcome of public health measure or product of incomplete data? [PDF]
Del Castillo FA.
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Handling errors in the response: Considerations for leveraging unsupervised or incomplete data for genetic evaluations. [PDF]
Wu XL +4 more
europepmc +1 more source

